Menu
Back to User profile » Prof. Dr. Ian Douglas Pavord
Papers published by Prof. Dr. Ian Douglas Pavord:
Dupilumab Improves Outcomes in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma Irrespective of Baseline Asthma Characteristics
Busse WW, Pavord ID, Siddiqui S, Khan AH, Praestgaard A, Nash S, Jacob-Nara JA, Rowe PJ, Deniz Y
Journal of Asthma and Allergy 2023, 16:411-419
Published Date: 18 April 2023
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy
Chen S, Miravitlles M, Rhee CK, Pavord ID, Jones R, Carter V, Emmanuel B, Alacqua M, Price DB
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2187-2200
Published Date: 9 September 2022
Risk Predictors and Symptom Features of Long COVID Within a Broad Primary Care Patient Population Including Both Tested and Untested Patients
Jones R, Davis A, Stanley B, Julious S, Ryan D, Jackson DJ, Halpin DMG, Hickman K, Pinnock H, Quint JK, Khunti K, Heaney LG, Oliver P, Siddiqui S, Pavord I, Jones DHM, Hyland M, Ritchie L, Young P, Megaw T, Davis S, Walker S, Holgate S, Beecroft S, Kemppinen A, Appiagyei F, Roberts EJ, Preston M, Hardjojo A, Carter V, van Melle M, Price D
Pragmatic and Observational Research 2021, 12:93-104
Published Date: 11 August 2021
Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
Pavord ID, Chapman KR, Bafadhel M, Sciurba FC, Bradford ES, Schweiker Harris S, Mayer B, Rubin DB, Yancey SW, Paggiaro P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1755-1770
Published Date: 16 June 2021
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function
Pavord ID, Siddiqui S, Papi A, Corren J, Sher LD, Bardin P, Langton D, Park HS, Rice MS, Deniz Y, Rowe P, Staudinger HW, Patel N, Ruddy M, Graham NMH, Teper A
Journal of Asthma and Allergy 2020, 13:701-711
Published Date: 16 December 2020
Asthma impacts on workplace productivity in employed patients who are symptomatic despite background therapy: a multinational survey
Gruffydd-Jones K, Thomas M, Roman-Rodríguez M, Infantino A, FitzGerald JM, Pavord I, Haddon JM, Elsasser U, Vogelberg C
Journal of Asthma and Allergy 2019, 12:183-194
Published Date: 11 July 2019
The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
Russell REK, Beer S, Pavord ID, Pullinger R, Bafadhel M
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:971-977
Published Date: 7 May 2019
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
Siddiqui SH, Pavord ID, Barnes NC, Guasconi A, Lettis S, Pascoe S, Petruzzelli S
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3669-3676
Published Date: 6 November 2018
Exacerbations of COPD
Pavord ID, Jones PW, Burgel PR, Rabe KF
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:21-30
Published Date: 19 February 2016
Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
Bafadhel M, Haldar K, Barker B, Patel H, Mistry V, Barer MR, Pavord ID, Brightling CE
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1075-1083
Published Date: 9 June 2015
Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease
Barker BL, McKenna S, Mistry V, Pancholi M, Patel H, Haldar K, Barer MR, Pavord ID, Steiner MC, Brightling CE, Bafadhel M
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:975-981
Published Date: 15 September 2014
Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
Siva R, Bafadhel M, Monteiro W, Brightling CE, Pavord ID
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:179-186
Published Date: 7 February 2014